Who Paid My Doc
Erwinaze
Drug Hematology/Oncology
NDC 57902-249-05
General payments
$14,833
Research payments
$0
Through program year 2024, $14,833 in general payments and $0 in research payments were reported against Erwinaze (Hematology/Oncology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $42 | 2 |
| 2023 | General | $2,133 | 2 |
| 2021 | General | $77 | 1 |
| 2020 | General | $12,581 | 23 |
Breakdown
Each share is of general payments naming this product in 2024.
Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2024 where a state was reported.
Records
28 generalEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.